Ubs Group Ag Eargo, Inc. Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.7 - $3.0 $8,573 - $36,744	12,248 Added 82.88%	27,026 $28,000
Q2 2022 Aug 10, 2022	BUY	$0.75 - $5.6 $11,083 - $82,756	14,778 New	14,778 $11,000
Q1 2022 May 16, 2022	SELL	$3.3 - $7.28 $44,866 - $98,978	-13,596 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.6 - $10.21 $61,575 - $136,671	13,386 Added 6374.29%	13,596 $70,000
Q3 2021 Nov 15, 2021	SELL	$6.59 - $38.71 $6,438 - $37,819	-977 Reduced 82.31%	210 $1,000
Q2 2021 Aug 13, 2021	SELL	$32.1 - $57.78 $36,947 - $66,504	-1,151 Reduced 49.23%	1,187 $47,000
Q1 2021 May 12, 2021	SELL	$42.5 - $75.37 $21,760 - $38,589	-512 Reduced 17.96%	2,338 $117,000
Q4 2020 Feb 11, 2021	BUY	$33.49 - $57.94 $95,446 - $165,129	2,850 New	2,850 $127,000

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.